Octant Bio
Signal active
Organization
Contact Information
Overview
Octant Bio is a developer of synthetic technology used to improve health and treat disease. Its technology uses synthetic biology, genome engineering, next-generation sequencing, and computational tools to simultaneously measure the activity of thousands of receptor pathways in human cells that enable scientists to apply machine learning methods to engineer small molecules that interact with multiple receptors and unlock a new potential to treat complex diseases.
About
Industries
Biotechnology, Life Science
Founded
2017
Employees
51-100
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Octant Bio headquartered in United States, North America, operates in the Biotechnology, Life Science sector. The company focuses on Biotechnology and has secured $2.8B in funding across 24 round(s). With a team of 51-100 employees, Octant Bio is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - Octant Bio, raised $80.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
8
Lead Investors
0
Total Funding Amount
$115.0M
Details
3
Octant Bio has raised a total of $115.0M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2017 | Seed | 5.0M | ||
| 2020 | Early Stage Venture | 30.0M | ||
| 2022 | Early Stage Venture | 80.0M |
Investors
Octant Bio is funded by 33 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| What If Ventures | - | FUNDING ROUND - What If Ventures | 80.0M |
| Flucas Ventures | - | FUNDING ROUND - Flucas Ventures | 80.0M |
| Octant Bio | - | FUNDING ROUND - Octant Bio | 80.0M |
| Bioverge | - | FUNDING ROUND - Bioverge | 80.0M |
Recent Activity
There is no recent news or activity for this profile.